Hikma Pharmaceuticals PLC
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
6/10
|
26.6 | 0 | 0% | 18.98 | +40.16% |
| P/S |
|
1.76 | 0 | 0% |
|
|
| P/BV |
|
2.29 | 0 | 0% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
6.94 | 0 | 0% |
|
|
| Ev/S |
|
2.1 | 0 | 0% |
|
|
| Ev/FCF |
|
14.95 | 0 | 0% |
|
|
| E/P |
|
0 | 0 | 0% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
30.3 | 0 | 0% | 25.5 | +18.81% |
| ROE |
|
8.64 | 0 | 0% |
|
|
| ROA |
|
4.06 | 0 | 0% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
6.61 | 0 | 0% |
|
|
| ROCE |
|
30.57 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
8/10
|
1.3 | 0 | 0% | 1.7 | -23.15% |
| Nеt Debt/Ebitda |
|
1.13 | 0 | 0% |
|
|
| Debt/Ratio |
|
0.2427 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
5.98 | 0 | 0% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
7.88/10
|
3.15 | 0 | 0% | 2.46 | +28% |
| Number of years of dividend growth |
|
7 | 0 | 0% | ||
| DSI |
|
1 | 0 | 0% |
|
|
| Average dividend growth |
|
12.22 | 0 | 0% |
|
|
| Average percentage for 5 years |
|
2.46 | 0 | 0% |
|
|
| Average percentage for payments |
|
29.82 | 0 | 0% |
|
|
| Difference from average difference in sector |
|
3.15 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
5/10
|
30.09 | 0 | 0% | ||
| Growth impulse Ebitda in 5 years |
|
-8.99 | 0 | 0% | ||
| Growth impulse Net Income in 5 years |
|
-60.91 | 0 | 0% | ||
| Growth impulse FCF in 5 years |
|
41.26 | 0 | 0% | ||
| Growth impulse EPS in 5 years |
|
-57.49 | 0 | 0% |
IP Score
5.88/10
